Iglesias VY, Figueredo GLI, Guerra FIC

Language: Spanish
References: 10
Page:
PDF size: 342.00 Kb.

ABSTRACT

Paraganglioma is a rare tumor of neuroectodermal origin derived from the autonomic nervous system. A 52-year-old male patient, rural origin with a health history, comes to the office. The patient attended the consultation, reporting that for more than 6 months he had an increase in volume in the left lateral region of the neck, which was progressively increasing in size, without presenting pain. An incision biopsy was performed, which confirmed a seromatous papillary angioendothelioma; After excerilysis, he presented dehiscence of the wound and an increase in the size of the lesion in the form of an ulcerated lesion of more than 10cm, for which he was referred to the Oncological Hospital of Santiago de Cuba, a center where his registration was decided to evaluate the start of cancer-specific treatment. In the examination of the lamina a ganglioma is diagnosed histopathologically, suggesting study in a national reference center. Surgical treatment was applied. The treatment of choice was surgery with its prior embolization. Long-term follow-up of the patient was recommended due to the high recurrent risk of illness.

REFERENCES

1. Brito JP, Asi N, Gionfriddo M, Norman C, Lepin A, Zeballos Palacios C, et al. The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: A systematic review. Endocrine 2015; 50(1): 176-86.

2. Breen W, Bancos I, Young WF, Bible KC, Laak NN, Foote RL, et al. External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma. Adv Radiat Oncol 2018; 3(1): 25-9.

3. Instituto Nacional del Cáncer. Tratamiento de feocromocitomas y paragangliomas [PDQ®]: versión para el profesional de salud. Cancer.gov [Internet]. 2020 [citado 2/11/2020]. Disponible en: https://www.cancer.gov/espanol/tipos/feocromocitoma/pro/tratamiento-feocromocitoma-pdq

4. Clínica de predisposición al cáncer. Síndromes de paraganglioma-feocromocitoma hereditario. ST. Jude Childrens Research Hospital. [Internet]. 2020 [citado 8/12/2020]. Disponible en: https://www.stjude.org/content/dam/en_US/shared/www/patient-support/genetic-summaries/spanish/sindrome-de-paraganglioma-feocromocitoma-hereditario.pdf

5. Young W, Oh K. Paragangliomas: Treatment of locoregional disease. UpToDaTe. [Internet]. 2020 [citado 8/7/2020]. Disponible en: https://www.uptodate.com/contents/paragangliomas-treatment-of-locoregional-disease

6. Young W, Elfiky A. Paraganglioma and pheochromocytoma: Management of malignant disease. UpToDaTe. [Internet]. 2020 [citado 8/7/2020]. Disponible en: https://www.uptodate.com/contents/paraganglioma-and-pheochromocytoma-management-of-malignant-disease

7. Mayo Clinic. Paraganglioma. Mayoclinic.org. [Internet]. 2020 [citado 8/7/2020]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/paraganglioma/cdc-20352970

8. Black HR. Secondary hypertension: Pheochromocytoma. En: Hypertension: A Companion to Braunwald’s Heart Disease. 2.ª ed. Filadelfia: Elsevier/Saunders; 2013.

9. Lenders JW, Yan Du Q, Eisenhofer G, Jiménez Roqueplo AP, Grebe S, Hassan Murad M, et al. Pheochromocytoma and paraganglioma: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism 2014; 99(6): 1915-42.

10. Mayo Clinic. Feocromocitoma. Mayoclinic.org. [Internet]. 2020 [citado 8/7/2020]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/pheochromocytoma/diagnosis-treatment/drc-20355372